In the presence of the irreversible MAO-A inhibitor clorgyline at a concentration of 1 μM, over 90% of [18F]FAZIN3 binding was displaced in the AD subjects (Figure 3E,F). This evidence concerns the gene MAOA and Alzheimer disease.